If you need more lookups,
subscriptions start at $34 USD/month.
Emma Bowden Location
Indianapolis, IN, US
Emma Bowden Work
Senior Vice President, Head of Development @ (July 2024 - Present)
Vice President, Head of Clinical Development @ (September 2023 - Present)
Vice President, Clinical and Non-Clinical Development @ (May 2023 - August 2023)
Vice President, Program Development @ (July 2022 - April 2023)
Senior Director, Program Leader @ (April 2021 - July 2022)
Clinical Asset Manager @ Eli Lilly and Company (February 2018 - April 2021)
Research Advisor, Oncology Tailored Therapeutics @ Eli Lilly and Company (August 2015 - January 2018)
Director, Translational Oncology @ (March 2012 - July 2015)
Scientist and Group Lead @ (February 2005 - March 2012)
Assistant Professor @ (April 1995 - February 2005)
Research Instructor @ (January 2001 - January 2003)
Emma Bowden Education
University of Bristol Law School
Doctor of Philosophy (Biochemistry)
1992-1995
University of Kent
Bachelor of Science (Biochemistry)
1987-1991
Emma Bowden Skills
Drug Discovery
Drug Development
Cell Biology
Oncology
Research
CRO
Cancer
Bioinformatics
Biotechnology
In Vivo
Clinical Development
Translational Medicine
Assay Development
Antibodies
In Vitro
Clinical Trials
Biomarker Discovery
Biomarkers
Stem Cells
Life Sciences
Molecular Biology
Cell
Genomics
Biochemistry
Cell Culture
Writing Services
Marketing Development
Talent Management
Event Management
Project Management
Emma Bowden Summary
Emma Bowden, based in Indianapolis, IN, US, is currently a Senior Vice President, Head of Development at QurAlis. Emma Bowden brings experience from previous roles at QurAlis, Nutcracker Therapeutics and Sangamo Therapeutics, Inc.. Emma Bowden holds a 1992 - 1995 Doctor of Philosophy in Biochemistry @ University of Bristol Law School. With a robust skill set that includes Drug Discovery, Drug Development, Cell Biology, Oncology, Research and more. Emma Bowden has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Emma Bowden?
Find contact details for 700 million professionals.